All Stories

  1. Investigation of In vitro and In Silico Anticholinesterase Activities of Hydrazones Bearing 4-Iodobenzohydrazide Scaffolds
  2. Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies
  3. Novel Pyrrolidine-Based Pyrazolines as α-Glucosidase Inhibitors: Microwave-Assisted Synthesis, Antidiabetic Activity, In Silico ADMET Prediction, Molecular Docking, and Molecular Dynamics Simulations
  4. Design, Synthesis, Antidiabetic Activity and In Silico Studies of New Hydrazone Derivatives Derived from Acetohexamide
  5. Synthesis, Conformational Analysis, Antioxidant and Enzyme Inhibition Activity, Molecular Docking, and DFT Studies of New Chiral Hydrazide–Hydrazone Derivatives
  6. Thiophene-based hydrazones and their metal complexes: Synthesis, structure affirmation, antioxidant and cytotoxic activity, photoluminescence, molecular docking, and ADMET studies
  7. Discovery of Novel Pyrrolidine-Based Chalcones as Dual Inhibitors of α-Amylase and α-Glucosidase: Synthesis, Molecular Docking, ADMET Profiles, and Pharmacological Screening
  8. Homoleptic metal complexes derived from hydrazones as ligand; synthesis, cytotoxic activity, photoluminescence properties and ADMET studies
  9. Discovery of New Dual-Target Agents Against PPAR-γ and α-Glucosidase Enzymes with Molecular Modeling Methods: Molecular Docking, Molecular Dynamic Simulations, and MM/PBSA Analysis
  10. Determination Of Inhibitory Effects of Newly Synthesized Potential HIF Inhibitors on Non-Small Cell Lung Cancer Under Hypoxic Conditions
  11. Design, Synthesis, Pharmacological Activities, Structure–Activity Relationship, and In Silico Studies of Novel 5-Substituted-2-(morpholinoimino)-thiazolidin-4-ones
  12. Investigation of α‐glucosidase and α‐amylase inhibitory effects of phenoxy chalcones and molecular modeling studies
  13. Synthesis, Antiproliferative Activity and In Silico Studies of Chalcones Derived From 4-(Imidazole-1-yl)Acetophenone
  14. Design, in Silico Studies and Biological Evaluation of New Chiral Thiourea and 1,3‐Thiazolidine‐4,5‐dione Derivatives
  15. Chalcones bearing nitrogen‐containing heterocyclics as multi‐targeted inhibitors: Design, synthesis, biological evaluation and molecular docking studies
  16. Benzoik Asitli Kalkonların Ksantin Oksidaz İnhibitörü Üzerine Etkisinin İncelenmesi
  17. Synthesis and biological activities of new hybrid chalcones with benzoic acid ring
  18. Synthesis, Antioxidant and Some Enzyme Inhibition Activities of New Sulfonyl Hydrazones and their Molecular Docking Simulations
  19. Experimental, spectroscopic and theoretical investigation of (+)-(R)-5-[1-(Benzenesulfonamido)-2-phenylethyl]-4-phenethyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
  20. Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding affinity, in vitro antitumoral activities and in silico studies
  21. The anticancer activity of chalcone compounds against human prostate carcinoma cell and human colon colorectal adenocarcinoma
  22. Synthesis of benzoyl hydrazones having 4-hydroxy-3,5-dimethoxy phenyl ring, their biological activities and moleculer modeling studies on enzyme inhibition activities
  23. One pot synthesis and spectral characterization of 5-Substitutedfuran-2-carbaldehyde N4-cyclohexyl thiosemicarbazones and their Ni(II) complexes
  24. Synthesis, characterization, antituberculosis activity and computational studies on novel Schiff bases of 1,3,4-thiadiazole derivatives
  25. Design and Bioevaluation of Novel Hydrazide-Hydrazones Derived from 4-Acetyl-N-Substituted Benzenesulfonamide
  26. Designing heterocyclic chalcones, benzoyl/sulfonyl hydrazones: An insight into their biological activities and molecular docking study
  27. Effect of Gum, Protein and Emulsifier Use at Different Ratios and Gelatinization on Rice Pasta Quality
  28. Synthesis, characterization, and antioxidant and anticholinesterase activities of pyrazolo derivatives
  29. Novel fluorine-containing chiral hydrazide-hydrazones: Design, synthesis, structural elucidation, antioxidant and anticholinesterase activity, and in silico studies
  30. Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents
  31. synthesis and activity of heterocyclic compounds
  32. Synthesis of novel chiral metal complexes derived from chiral thiosemicarbazide ligands as potential antioxidant agents
  33. Design and evaluation of biological activities of 1,3-oxazolidinone derivatives bearing amide, sulfonamide, and thiourea moieties
  34. Synthesis, characterization, spectroscopy, X-ray structure and gaussian hybrid computational investigation of (−)-(S)-1-[2-(benzenesulfonamido)-3-phenylpropanoyl]-4-[(4-methyl)phenyl]thiosemicarbazide
  35. Synthesis and biological evaluation of novel chalcones bearing morpholine moiety as antiproliferative agents
  36. Synthesis of novel fluorinated chalcones derived from 4′-morpholinoacetophenone and their antiproliferative effects
  37. Synthesis and structure-activity relationship study: Anticancer chalcones derived from 4'-morpholinoacetophenone
  38. X-ray structures and spectroscopic properties of chiral thiosemicarbazides as studied by computational calculations
  39. Design and Synthesis of Novel Thioureas Derived from 4-(4-Fluorophenoxy)aniline as Anticancer Agents
  40. The potential BChE inhibitor
  41. Synthesis of Novel Chiral Sulfonamide-Bearing 1,2,4-Triazole-3-thione Analogs Derived fromD-andL-Phenylalanine Esters as Potential Anti-Influenza Agents
  42. Microwave-assisted synthesis of new sulfonyl hydrazones, screening of biological activities and investigation of structure–activity relationship
  43. Studies on Hydrazide-Hydrazon Derivatives As Acetylcholinesterase Inhibitors
  44. Synthesis, Molecular Modeling, and Biological Evaluation of Novel Chiral Thiosemicarbazone Derivatives as Potent Anticancer Agents
  45. Synthesis, Characterization, and Biological Evaluation of Some Novel Thiosemicarbazones as Possible Antibacterial and Antioxidant Agents
  46. Supercritical Carbon Dioxide Fractionation of Anhydrous Milk Fat
  47. Biting deterrence and insecticidal activity of hydrazide-hydrazones and their corresponding 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazoles against Aedes aegypti
  48. Synthesis and biological activity of hydrazide–hydrazones and their corresponding 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazoles
  49. Novel platinum(II) and palladium(II) complexes of thiosemicarbazones derived from 5-substitutedthiophene-2-carboxaldehydes and their antiviral and cytotoxic activities
  50. Anticonvulsant activity of 3,5-dimethylpyrazole derivatives in animal models
  51. Antituberculosis activity of hydrazones derived from 4-fluorobenzoic acid hydrazide
  52. Synthesis and characterization of novel hydrazide–hydrazones and the study of their structure–antituberculosis activity
  53. Synthesis of Some Novel Azo Derivatives of 3,5-Dimethly-1-(2-hydroxyethyl)pyrazole as Potent Analgesic Agents
  54. The in vivo metabolism of 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine in rats
  55. High-pressure liquid chromatographic analysis for identification of in vitro and in vivo metabolites of 4-phenethyl-5-[4-(1-(2-hydroxyethyl)-3,5-dimethyl-4-pyrazolylazo)phenyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats
  56. 1,3,4-Thiadiazole Derivatives. Synthesis, Structure Elucidation, and Structure−Antituberculosis Activity Relationship Investigation
  57. Thein vivo metabolism of 5-(4-nitrophenyl)-4-(2-phenylethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats
  58. Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds
  59. In vivo metabolism of 4-fluorobenzoic acid [(5-nitro-2-furanyl) methylene] hydrazide in rats
  60. THE IN VITRO HEPATIC MICROSOMAL METABOLISM OF 3,5-DIMETHYL-4-(PHENYLAZO)-(1H)-PYRAZOLE IN RATS
  61. THE IN VIVO METABOLISM OF 5-(4-NITROPHENYL)- 4-PHENYL-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE IN RATS